Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2023 Filed Feb 21, 2023 13:33 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 15,000 | $14.08 | $211,161.00 |
DisclosureSEC source: 0000784199-23-000024 · wf-form4_167698637076316.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,663 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2022 F2 · price: Reflects weighted average price. Range of prices were between $13.79 to $15.18. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full informationregarding the number of shares sold at each separate price. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 13:33 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 17,713 | $10.24 | $181,381.12 |
DisclosureSEC source: 0000784199-23-000024 · wf-form4_167698637076316.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2022 Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 13:29 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 2,740 | $13.96 | $38,250.40 |
DisclosureSEC source: 0000784199-23-000022 · wf-form4_167698613905019.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,944 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 13:26 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 586 | $13.96 | $8,180.56 |
DisclosureSEC source: 0000784199-23-000020 · wf-form4_167698597757603.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,431 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:41 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionStock Options (Right to buy) · Derivative | 36,822 | $10.24 Strike: $10.24 | $377,057.28 |
DisclosureSEC source: 0000784199-23-000018 · wf-form4_167658725067482.xml · derivative · entry 4 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,822 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:41 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
SaleCommon Stock | 31,900 | $13.22 | $421,874.31 |
DisclosureSEC source: 0000784199-23-000018 · wf-form4_167658725067482.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,563 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2022 F2 · price: Reflects the price of $ 13.224856 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:41 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionCommon Stock | 36,822 | $10.24 | $377,057.28 |
DisclosureSEC source: 0000784199-23-000018 · wf-form4_167658725067482.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2022 Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:36 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionStock Options (Right to buy) · Derivative | 65,549 | $10.24 Strike: $10.24 | $671,221.76 |
DisclosureSEC source: 0000784199-23-000016 · wf-form4_167658695692379.xml · derivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Commn Stock · 65,549 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:36 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 56,500 | $13.22 | $747,206.85 |
DisclosureSEC source: 0000784199-23-000016 · wf-form4_167658695692379.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,684 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2022 F2 · price: Reflects the price of $ 13.224856 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:36 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionCommon Stock | 65,549 | $10.24 | $671,221.76 |
DisclosureSEC source: 0000784199-23-000016 · wf-form4_167658695692379.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2022 Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 13:48 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionStock Options (Right to buy) · Derivative | 8,745 | $10.24 Strike: $10.24 | $89,548.80 |
DisclosureSEC source: 0000784199-23-000010 · wf-form4_167646887551493.xml · derivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,745 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 13:48 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 8,745 | $10.24 | $89,548.80 |
DisclosureSEC source: 0000784199-23-000010 · wf-form4_167646887551493.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 22:24 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 443 | $10.30 | $4,563.79 |
DisclosureSEC source: 0000784199-23-000008 · wf-form5_167485824303268.xml · nonDerivative · entry 2 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,448 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 22:24 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 810 | $16.05 | $12,998.88 |
DisclosureSEC source: 0000784199-23-000008 · wf-form5_167485824303268.xml · nonDerivative · entry 1 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,005 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 22:16 UTC |
Maier Dennis BSVP, Operations
|
GrantCommon Stock | 211 | $16.05 | $3,386.13 |
DisclosureSEC source: 0000784199-23-000004 · wf-form5_167485779779342.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,465 F1 · balance_after: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 22:13 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 1,228 | $16.05 | $19,706.94 |
DisclosureSEC source: 0000784199-23-000002 · wf-form5_167485759076159.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,272 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 22:21 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 384 | $10.30 | $3,955.97 |
DisclosureSEC source: 0000784199-23-000006 · wf-form5_167485806958539.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,883 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 22:21 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 866 | $16.05 | $13,897.57 |
DisclosureSEC source: 0000784199-23-000006 · wf-form5_167485806958539.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,499 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 13:35 UTC |
Horton AmyVP, Chief Accounting Officer
|
GiftCommon Stock | 2,000 | $13.21 | $26,420.00 |
DisclosureSEC source: 0000784199-22-000219 · wf-form4_167119772855070.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,950 F2 · price: Shares were gifted by the reporting person to a charity Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 13:35 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 3,226 | $13.57 | $43,782.63 |
DisclosureSEC source: 0000784199-22-000219 · wf-form4_167119772855070.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,950 F1 · price: Reflects weighted average price. Range of prices were between $13.56 to $13.60. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer,full information regarding the number of shares sold at each separate price. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 21:23 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock · Derivative | 28,370 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000217 · wf-form4_166811539245674.xml · derivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,370 Underlying: Common Stock · 28,370 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 21:23 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 11,831 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000217 · wf-form4_166811539245674.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,176 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 21:21 UTC |
Barthold Franz PeterVP, Research & Development
|
GrantCommon Stock · Derivative | 30,000 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000216 · wf-form4_166811526069083.xml · derivative · entry 2 Barthold Franz Peter · CIK 0001806854 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 21:21 UTC |
Barthold Franz PeterVP, Research & Development
|
GrantCommon Stock | 12,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000216 · wf-form4_166811526069083.xml · nonDerivative · entry 1 Barthold Franz Peter · CIK 0001806854 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,516 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:29 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock · Derivative | 46,630 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000213 · wf-form4_166809057926995.xml · derivative · entry 2 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,630 Underlying: Common Stock · 46,630 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:29 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 19,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000213 · wf-form4_166809057926995.xml · nonDerivative · entry 1 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,195 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:28 UTC |
GREEN ANDREW MVP Regulatory
|
GrantCommon Stock · Derivative | 30,000 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000211 · wf-form4_166809046298138.xml · derivative · entry 2 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:28 UTC |
GREEN ANDREW MVP Regulatory
|
GrantCommon Stock | 12,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000211 · wf-form4_166809046298138.xml · nonDerivative · entry 1 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,831 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:22 UTC |
Getz Matthew AVP, Human Resources
|
GrantCommon Stock · Derivative | 31,630 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000209 · wf-form4_166809011443597.xml · derivative · entry 2 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,630 Underlying: Common Stock · 31,630 shares Expires 2029-11-01 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:22 UTC |
Getz Matthew AVP, Human Resources
|
GrantCommon Stock | 13,191 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000209 · wf-form4_166809011443597.xml · nonDerivative · entry 1 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,902 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:20 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommn Stock · Derivative | 53,478 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000207 · wf-form4_166808999730354.xml · derivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,478 Underlying: Common Stock · 53,478 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:20 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 22,303 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000207 · wf-form4_166808999730354.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,044 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:17 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock · Derivative | 88,043 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000205 · wf-form4_166808986340131.xml · derivative · entry 3 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,043 Underlying: Common Stock · 88,043 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:17 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock | 36,718 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000205 · wf-form4_166808986340131.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,641 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:15 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock · Derivative | 53,804 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000203 · wf-form4_166808972814384.xml · derivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,804 Underlying: Common Stock · 53,804 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:15 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 22,439 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000203 · wf-form4_166808972814384.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,633 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:13 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock · Derivative | 280,435 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000201 · wf-form4_166808958465093.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,435 Underlying: Commn Stock · 280,435 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:13 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 116,954 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000201 · wf-form4_166808958465093.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,635 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:02 UTC |
Hoff Elizabeth ADirector
|
GrantCommon Stock | 9,066 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000199 · wf-form4_166808892795911.xml · nonDerivative · entry 1 Hoff Elizabeth A · CIK 0001949762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,066 F1 · shares: 1. Represents shares of restricted stock that cliff vest on November 8, 2023, provided the status as a Director with Artivion continues through such date. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 13:55 UTC |
Maier Dennis BSVP, Operations
|
GrantCommon Stock · Derivative | 46,630 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000195 · wf-form4_166808853002623.xml · derivative · entry 2 Maier Dennis B · CIK 0001742150 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,630 Underlying: Common Stock · 46,630 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 13:55 UTC |
Maier Dennis BSVP, Operations
|
GrantCommon Stock | 19,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000195 · wf-form4_166808853002623.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,254 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:00 UTC |
Maney Rochelle L.VP, Quality
|
GrantCommon Stock · Derivative | 28,370 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0000784199-22-000197 · wf-form4_166808879058202.xml · derivative · entry 2 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,370 Underlying: Common Stock · 28,370 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 14:00 UTC |
Maney Rochelle L.VP, Quality
|
GrantCommon Stock | 11,831 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-22-000197 · wf-form4_166808879058202.xml · nonDerivative · entry 1 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,942 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 21:53 UTC |
Maney Rochelle L.VP, Quality
|
Tax withholdingCommon Stock | 214 | $11.18 | $2,392.52 |
DisclosureSEC source: 0000784199-22-000191 · wf-form4_166785799918965.xml · nonDerivative · entry 1 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,111 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:24 UTC |
Maney Rochelle L.VP, Quality
|
SaleCommon Stock | 7,161 | $22.96 | $164,409.40 |
DisclosureSEC source: 0000784199-22-000168 · wf-form4_166085425002465.xml · nonDerivative · entry 1 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,325 F1 · price: Reflects weighted average price. Range of prices were between $22.93 to $23.01. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 21:12 UTC |
Maier Dennis BSVP, Operations
|
SaleCommon Stock | 1,025 | $21.61 | $22,148.10 |
DisclosureSEC source: 0000784199-22-000165 · wf-form4_166016587852712.xml · nonDerivative · entry 5 Maier Dennis B · CIK 0001742150 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,807 F2 · price: Reflects weighted average price. Range of prices were between $21.40 to $21.85. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 21:12 UTC |
Maier Dennis BSVP, Operations
|
SaleCommon Stock | 374 | $21.61 | $8,081.35 |
DisclosureSEC source: 0000784199-22-000165 · wf-form4_166016587852712.xml · nonDerivative · entry 4 Maier Dennis B · CIK 0001742150 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,832 F2 · price: Reflects weighted average price. Range of prices were between $21.40 to $21.85. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 21:12 UTC |
Maier Dennis BSVP, Operations
|
SaleCommon Stock | 540 | $21.61 | $11,668.27 |
DisclosureSEC source: 0000784199-22-000165 · wf-form4_166016587852712.xml · nonDerivative · entry 3 Maier Dennis B · CIK 0001742150 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,206 F2 · price: Reflects weighted average price. Range of prices were between $21.40 to $21.85. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 21:12 UTC |
Maier Dennis BSVP, Operations
|
SaleCommon Stock | 3,678 | $21.61 | $79,473.86 |
DisclosureSEC source: 0000784199-22-000165 · wf-form4_166016587852712.xml · nonDerivative · entry 2 Maier Dennis B · CIK 0001742150 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,746 F2 · price: Reflects weighted average price. Range of prices were between $21.40 to $21.85. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 21:12 UTC |
Maier Dennis BSVP, Operations
|
SaleCommon Stock | 145 | $21.67 | $3,141.43 |
DisclosureSEC source: 0000784199-22-000165 · wf-form4_166016587852712.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,424 F1 · price: Reflects the price of $21.665 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.